Navigating Aspen Pharmacare's Performance Amidst COVID-19 Challenges and Vaccine Manufacturing Optimism|Stephen Saad, CEO, Aspen Pharmacare Holdings Ltd. 00:10:00
Stephen Saad, the CEO of Aspen Pharmacare, discusses the company's performance during the COVID-19 pandemic and its involvement in manufacturing COVID-19 vaccines. Despite the challenges posed by the pandemic, Aspen's strategy has proven successful, with a focus on critical medicines and steroids. Saad expresses optimism about the company's outlook and the potential for continued success in vaccine manufacturing, particularly in South Africa.
